130 related articles for article (PubMed ID: 33528935)
1. 22q11.2 deletion syndrome: 20 years of experience from two pediatric immunology units and review of clues for diagnosis and disease management.
Ozen S; Akcal O; Taskirdi I; Haci IA; Karaca NE; Gulez N; Aksu G; Genel F; Kutukculer N
Allergol Immunopathol (Madr); 2021; 49(1):95-100. PubMed ID: 33528935
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and follow-up in patients with 22q11.2 deletion syndrome.
Cancrini C; Puliafito P; Digilio MC; Soresina A; Martino S; Rondelli R; Consolini R; Ruga EM; Cardinale F; Finocchi A; Romiti ML; Martire B; Bacchetta R; Albano V; Carotti A; Specchia F; Montin D; Cirillo E; Cocchi G; Trizzino A; Bossi G; Milanesi O; Azzari C; Corsello G; Pignata C; Aiuti A; Pietrogrande MC; Marino B; Ugazio AG; Plebani A; Rossi P;
J Pediatr; 2014 Jun; 164(6):1475-80.e2. PubMed ID: 24657119
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and molecular diagnosis of three patients with DiGeorge anomaly].
Sun JQ; Wang LS; Qi CH; Ying WJ; Guo XH; Liu DR; Hui XY; Liu F; Cao Y; Luo FH; Wang XC
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):944-7. PubMed ID: 23324155
[TBL] [Abstract][Full Text] [Related]
4. The Immune Phenotype of Patients with CHARGE Syndrome.
Hsu P; Ma A; Barnes EH; Wilson M; Hoefsloot LH; Rinne T; Munns C; Williams G; Wong M; Mehr S
J Allergy Clin Immunol Pract; 2016; 4(1):96-103.e2. PubMed ID: 26563674
[TBL] [Abstract][Full Text] [Related]
5. Deletion 22q11.2 syndrome--implications for the intensive care physician.
Jatana V; Gillis J; Webster BH; Adès LC
Pediatr Crit Care Med; 2007 Sep; 8(5):459-63; quiz 464. PubMed ID: 17873780
[TBL] [Abstract][Full Text] [Related]
6. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
[TBL] [Abstract][Full Text] [Related]
7. Anatomic patterns of conotruncal defects associated with deletion 22q11.
Marino B; Digilio MC; Toscano A; Anaclerio S; Giannotti A; Feltri C; de Ioris MA; Angioni A; Dallapiccola B
Genet Med; 2001; 3(1):45-8. PubMed ID: 11339377
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of clinical dysimmune manifestations in a cohort of 86 children with 22q11.2 deletion syndrome: A retrospective study in France.
Mahé P; Nagot N; Portales P; Lozano C; Vincent T; Sarda P; Perez MJ; Amedro P; Marin G; Jeziorski E
Am J Med Genet A; 2019 Nov; 179(11):2207-2213. PubMed ID: 31471951
[TBL] [Abstract][Full Text] [Related]
9. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features.
Jyonouchi S; McDonald-McGinn DM; Bale S; Zackai EH; Sullivan KE
Pediatrics; 2009 May; 123(5):e871-7. PubMed ID: 19403480
[TBL] [Abstract][Full Text] [Related]
10. Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.
Suksawat Y; Sathienkijkanchai A; Veskitkul J; Jirapongsananuruk O; Visitsunthorn N; Vichyanond P; Pacharn P
J Clin Immunol; 2017 May; 37(4):375-382. PubMed ID: 28429103
[TBL] [Abstract][Full Text] [Related]
11. 22q11.2 deletion detected by
Ramírez-Velazco A; Rivera H; Vásquez-Velázquez AI; Aguayo-Orozco TA; Delgadillo-Pérez S; Domínguez MG
Colomb Med (Cali); 2018 Sep; 49(3):219-222. PubMed ID: 30410196
[TBL] [Abstract][Full Text] [Related]
12. Childhood manifestations of 22q11.2 deletion syndrome: A Finnish nationwide register-based cohort study.
Wahrmann S; Kainulainen L; Kytö V; Lempainen J
Acta Paediatr; 2023 Jun; 112(6):1312-1318. PubMed ID: 36867048
[TBL] [Abstract][Full Text] [Related]
13. Selective IgM deficiency and 22q11.2 deletion syndrome.
Kung SJ; Gripp KW; Stephan MJ; Fairchok MP; McGeady SJ
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):87-92. PubMed ID: 17650836
[TBL] [Abstract][Full Text] [Related]
14. FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities.
Yakut T; Kilic SS; Cil E; Yapici E; Egeli U
Pediatr Surg Int; 2006 Apr; 22(4):380-3. PubMed ID: 16463032
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.
Sullivan KE; Jawad AF; Randall P; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH
Clin Immunol Immunopathol; 1998 Feb; 86(2):141-6. PubMed ID: 9473376
[TBL] [Abstract][Full Text] [Related]
16. Difference of clinical phenotypes and immunological features of 22q11.2 deletion syndrome in north-eastern Thai children compare to western countries.
Wichajam K; Kampan J
J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S59-66. PubMed ID: 25816539
[TBL] [Abstract][Full Text] [Related]
17. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
[TBL] [Abstract][Full Text] [Related]
18. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia.
Campbell IM; Sheppard SE; Crowley TB; McGinn DE; Bailey A; McGinn MJ; Unolt M; Homans JF; Chen EY; Salmons HI; Gaynor JW; Goldmuntz E; Jackson OA; Katz LE; Mascarenhas MR; Deeney VFX; Castelein RM; Zur KB; Elden L; Kallish S; Kolon TF; Hopkins SE; Chadehumbe MA; Lambert MP; Forbes BJ; Moldenhauer JS; Schindewolf EM; Solot CB; Moss EM; Gur RE; Sullivan KE; Emanuel BS; Zackai EH; McDonald-McGinn DM
Am J Med Genet A; 2018 Oct; 176(10):2058-2069. PubMed ID: 30380191
[TBL] [Abstract][Full Text] [Related]
19. Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome.
Schindewolf E; Khalek N; Johnson MP; Gebb J; Coleman B; Crowley TB; Zackai EH; McDonald-McGinn DM; Moldenhauer JS
Am J Med Genet A; 2018 Aug; 176(8):1735-1741. PubMed ID: 30055034
[TBL] [Abstract][Full Text] [Related]
20. [Improvement of genetic diagnostic strategy in velo-cardio-facial syndrome].
Pânzaru M; Rusu C; Voloşciuc M; Braha E; Butnariu L; Ivanov I; Grămescu M; Popescu R; Caba L; Sireteanu A; Macovei M; Covic M; Gorduza EV
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):756-61. PubMed ID: 22046783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
